Document Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer
Document Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
Document Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: a 10-year experience
Document Correlation of Extreme Drug Resistance Assay Results and Progression-Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Document Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors
Document Metastatic Appendiceal Mucinous Adenocarcinoma to Well-Differentiated Diffuse Mesothelioma of the Peritoneal Cavity: A Mimicker of Florid Mesothelial Hyperplasia in Association With Neoplasms
Document Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: Analysis of surgical performance
Document Robotic transperitoneal infra-renal aortic lymphadenectomy in early-stage endometrial cancer
Document Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis
Document Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging
Document Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review
Document Primary Peritoneal low-grade serous carcinoma forming a mass in the colon mimicking a colonic primary carcinoma: a case report
Document Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer
Document Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging
Document Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation
Document Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
